BIOS Fund I, LP, 10% Owner at Lantern Pharma Inc. (LTRN), sold 101,843 shares at $3.40 ($344K) on 2025-06-10, disclosed to the SEC on 2025-06-13.
Open-market sale of $344k LTRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.40 | 1 | $3 | 0.0% |
| 2 | $3.40 | 2 | $7 | 0.0% |
| 3 | $3.40 | 3 | $10 | 0.0% |
| 4 | $3.40 | 5 | $17 | 0.0% |
| 5 | $3.40 | 45 | $153 | 0.0% |
| 6 | $3.40 | 103 |
| $350 |
| 0.1% |
| 7 | $3.40 | 171 | $581 | 0.2% |
| 8 | $3.40 | 293 | $996 | 0.3% |
| 9 | $3.40 | 338 | $1K | 0.3% |
| 10 | $3.38 | 2,886 | $10K | 2.8% |
| 11 | $3.38 | 6,601 | $22K | 6.5% |
| 12 | $3.38 | 10,925 | $37K | 10.7% |
| 13 | $3.38 | 18,678 | $63K | 18.3% |
| 14 | $3.38 | 18,678 | $63K | 18.3% |
| 15 | $3.38 | 21,557 | $73K | 21.2% |
| 16 | $3.38 | 21,557 | $73K | 21.2% |
| Total | $3.38 avg | 101,843 | $344K | 100% |
| Filing → |
| LTRN | SELL | 2022-11-09 | $2.5M | — | Filing → |